Edison Initiates Coverage on Lifeline Scientific

News provided by

Jun 10, 2015, 08:58 ET

LONDON, June 10, 2015 /PRNewswire/ --

Edison Investment Research, a leading international investment research firm, announces the initiation of full coverage of Lifeline Scientific

(Logo: http://photos.prnewswire.com/prnh/20130417/608168 )

Highlights of the analysis on Lifeline Scientific by Edison's healthcare analysts Emma Ulker and Franc Gregori include:

Lifeline Scientific (LSI) is a US-based medical devices company. The company sells products and services to improve outcomes for transplant patients. Its lead product, the LifePort Kidney Transporter, is marketed in over 28 countries. A machine preservation device for livers has been developed with a US launch anticipated in 2015.

Valuation multiples of 1.4x FY15 EV/sales and a FY15 P/E of 11.8x fail to reflect the base-case valuation of Lifeline let alone the growth prospects of LifePort Kidney Transporter in newer markets and the LifePort Liver Transporter launch anticipated in late 2015. Our DCF valuation using a WACC of 10% is £53m or 271p per share.

To download this report, please click here .

All reports published by Edison are available to download free of charge from its website http://www.edisongroup.com.

About Edison: Edison, the investment intelligence firm, is the future of investor interaction with corporates. Our team of over 100 analysts and investment professionals works with leading companies, fund managers and investment banks worldwide to support their capital markets activities. We provide services to more than 400 retained corporate and investor clients from our offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority (http://www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584).

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact:
Emma Ulker Edison Investment Research +44(0)20-3077-5738
Franc Gregori Edison Investment Research +44(0)20-3077-5728

[email protected]

Contact details: Learn more at http://www.edisongroup.com and connect with Edison on:

LinkedIn  http://www.linkedin.com/company/edison-investment-research
Twitter  http://www.twitter.com/Edison_Inv_Res
YouTube  http://www.youtube.com/edisonitv

SOURCE Edison Investment Research